SCHEMBL306157

SCHEMBL306157

CCNc1nccs1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6991855 0.98
Hydrochloric Acid SCHEMBL29174570 0.98 PKM (0.46)
SCHEMBL2170934 0.83
SCHEMBL12963536 0.82 SMN1; SMN2 (0.45)
SCHEMBL622574 0.81 MEN1 (0.45)
SCHEMBL648497 0.79 NPC1 (0.50)
SCHEMBL2226564 0.78
SCHEMBL6039575 0.78
SCHEMBL33105 0.78 L3MBTL1 (0.49)
SCHEMBL14420962 0.78 MEN1 (0.45)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 271 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119613424-A Multifunctional rhodamine 6G derivative connected with 2-thiazole ethylamine and preparation method and application thereof 苏州大学 2025-03-14 CN claimed
US-20070086981-A1 Delivery peptides, their constructs with active agents and use ORTHOGEN AG (DE) 2007-04-19 US claimed
EP-1694696-A1 DELIVERY PEPTIDES ,THEIR CONSTRUCTS WITH ACTIVE AGENTS AND USE ORTHOGEN Aktiengesellschaft (DE) 2006-08-30 EP claimed
WO-2005054279-A1 DELIVERY PEPTIDES, THEIR CONSTRUCTS WITH ACTIVE AGENTS AND USE ORTHOGEN AG (DE) 2005-06-16 WO claimed
US-4474876-A Flow cytometric analysis of histamine receptors TRUSTEES OF BOSTON UNIVERSITY (US) 1984-10-02 US claimed
US-20260116873-A1 APYRASE INHIBITORS TEXAS CROP SCIENCE INC (US) 2026-04-30 US disclosed
US-20260116872-A1 THIOPHENE BASED APYRASE INHIBITORS TEXAS CROP SCIENCE INC (US) 2026-04-30 US disclosed
US-12472186-B2 Pharmaceutical compositions and methods of treating cardiovascular diseases Cardix Therapeutics LLC (US) 2025-11-18 US disclosed
US-12410169-B2 Method for producing cyclic imide compound, composition, and compound FUJIFILM CORPORATION (JP) 2025-09-09 US disclosed
US-20250275539-A1 APYRASE INHIBITORS TEXAS CROP SCIENCE INC (US) 2025-09-04 US disclosed
CN-119613424-B Multifunctional rhodamine 6G derivative connected with 2-thiazole ethylamine and preparation method and application thereof 苏州大学 2025-06-06 CN disclosed
CN-119613424-B Multifunctional rhodamine 6G derivative connected with 2-thiazole ethylamine and preparation method and application thereof 苏州大学 2025-06-06 CN disclosed
WO-2001062297-A1 COMPOSITIONS AND METHODS FOR ENHANCING DRUG DELIVERY ACROSS BIOLOGICAL MEMBRANES AND TISSUES CELLGATE, INC. (US) 2001-08-30 WO disclosed
WO-2001034208-A1 TECHNIQUES AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE BY IN VIVO GENE DELIVERY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2001-05-17 WO disclosed
EP-1053025-A2 COMBINATION OF A NUCLEIC ACID AND A VASOACTIVE AGENT FOR ENHANCED GENE DELIVERY The Regents of the University of California (US) 2000-11-22 EP disclosed
WO-1999040945-A2 COMBINATION OF A NUCLEIC ACID AND A VASOACTIVE AGENT FOR ENHANCED GENE DELIVERY THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 1999-08-19 WO disclosed
EP-0574118-A1 Polycyclic dyes ZENECA LIMITED (GB) 1993-12-15 EP disclosed
EP-0511271-A1 THIAZOLE DERIVATIVES CEDONA PHARMACEUTICALS B.V. (NL) 1992-11-04 EP disclosed
WO-1991010656-A1 THIAZOLE DERIVATIVES CEDONA PHARMACEUTICALS B.V. (NL) 1991-07-25 WO disclosed
US-4474876-A Flow cytometric analysis of histamine receptors TRUSTEES OF BOSTON UNIVERSITY (US) 1984-10-02 US disclosed